Glaxosmithkline Company Profile Get Rating News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Glaxosmithkline company profile get rating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Glaxosmithkline Company Profile Get Rating Today - Breaking & Trending Today

Analysts Set GlaxoSmithKline plc (NYSE:GSK) PT at $1,248.67

GlaxoSmithKline plc (NYSE:GSK – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, two have given a buy recommendation and one has given a […] ....

United States , United Kingdom , Stifel Nicolaus , Financial Group , Advisors Asset Management Inc , Glaxosmithkline Company Profile Get Rating , Jpmorgan Chase Co , Greylin Investment Mangement Inc , Advisory Services Network , Dz Bank , Get Rating , Services Network , Investment Mangement , Advisors Asset Management , Asset Management , Smithkline Company Profile , Nyse Gsk ,

GlaxoSmithKline (LON:GSK) Price Target Raised to GBX 1,850 at Berenberg Bank

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

United States , United Kingdom , Emma Walmsley , Charles Bancroft , Berenberg Bank , Glaxosmithkline Company Profile Get Rating , Credit Suisse Group , Deutsche Bank Rese , Jpmorgan Chase Co , Jefferies Financial Group , Get Rating , Digital Look , Bank Rese , Suisse Group , Smithkline Company Profile ,

GlaxoSmithKline's (GSK) Equal Weight Rating Reiterated at Barclays

Barclays reissued their equal weight rating on shares of GlaxoSmithKline (LON:GSK – Get Rating) in a research report released on Monday, MarketBeat reports. The firm currently has a GBX 1,675 ($21.83) price objective on the stock. Several other brokerages have also recently commented on GSK. The Goldman Sachs Group set a GBX 2,000 ($26.06) target […] ....

United States , United Kingdom , Emma Walmsley , Charles Bancroft , Jpmorgan Chase Co , Glaxosmithkline Company Profile Get Rating , Goldman Sachs Group , Get Rating , Smithkline Company Profile , Lon Gsk , Reiterated Rating , Barclays Plc ,

UBS Group Analysts Give GlaxoSmithKline (LON:GSK) a GBX 1,790 Price Target

GlaxoSmithKline (LON:GSK – Get Rating) received a GBX 1,790 ($23.48) price target from equities researchers at UBS Group in a research note issued to investors on Monday, Borsen Zeitung reports. UBS Group’s price target indicates a potential upside of 0.35% from the company’s current price. Other equities research analysts also recently issued research reports about […] ....

United States , United Kingdom , Emma Walmsley , Charles Bancroft , Borsen Zeitung , Berenberg Bank , Glaxosmithkline Company Profile Get Rating , Deutsche Bank Aktiengesellschaft , Jpmorgan Chase Co , Jefferies Financial Group , Get Rating , Bank Aktiengesellschaft , Financial Group , Smithkline Company Profile , Lon Gsk , Set Price Target , Ubs Group Ag ,

Ellis Investment Partners LLC Increases Stock Position in GlaxoSmithKline plc (NYSE:GSK)

Ellis Investment Partners LLC boosted its stake in GlaxoSmithKline plc (NYSE:GSK – Get Rating) by 185.7% during the fourth quarter, HoldingsChannel reports. The firm owned 2,074 shares of the pharmaceutical company’s stock after buying an additional 1,348 shares during the period. Ellis Investment Partners LLC’s holdings in GlaxoSmithKline were worth $91,000 at the end of […] ....

United States , United Kingdom , Stifel Nicolaus , Morgan Stanley , Glaxosmithkline Company Profile Get Rating , Zacks Investment Research , Stratos Wealth Partners , America Corp , Kestra Advisory Services , Ellis Investment Partners , Dz Bank , Get Rating , Investment Partners , Wealth Partners , Advisory Services , Investment Research , Smithkline Company Profile , Visit Holdingschannel , Nyse Gsk , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,